Skip to main content

CORRECTION article

Front. Oncol., 30 December 2021
Sec. Head and Neck Cancer
Volume 11 - 2021 | https://doi.org/10.3389/fonc.2021.836903
This article is part of the Research Topic Prognosis Prediction and Risk Stratification in Head and Neck Cancer View all 59 articles

Corrigendum: Incidence and Prognostic Significance of PD-L1 Expression in High-Grade Salivary Gland Carcinoma

This article is a correction to:

  1. Incidence and Prognostic Significance of PD-L1 Expression in High-Grade Salivary Gland Carcinoma

    1. Read original article
Qigen Fang*Qigen Fang*Yao WuYao WuWei DuWei DuXu ZhangXu ZhangDefeng ChenDefeng Chen
  • Department of Head Neck and Thyroid, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China

A Corrigendum on:
Incidence and Prognostic Significance of PD-L1 Expression in High-Grade Salivary Gland Carcinoma

By Fang Q, Wu Y, Du W, Zhang X, Chen D. (2021) Front Oncol. 11:701181. doi: 10.3389/fonc.2021.701181

In the published article, there was an error in affiliation order. Instead of “Department of Head Neck and Thyroid, Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China”, it should be “Department of Head Neck and Thyroid, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: salivary gland carcinoma, PD-L1, immunotherapy, high-grade salivary gland carcinoma, survival

Citation: Fang Q, Wu Y, Du W, Zhang X and Chen D (2021) Corrigendum: Incidence and Prognostic Significance of PD-L1 Expression in High-Grade Salivary Gland Carcinoma. Front. Oncol. 11:836903. doi: 10.3389/fonc.2021.836903

Received: 16 December 2021; Accepted: 16 December 2021;
Published: 30 December 2021.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2021 Fang, Wu, Du, Zhang and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Qigen Fang, qigenfang@126.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.